Systems biology in the development of HIV vaccines.

Authors:
Address: Vaccine and Gene Therapy Institute, Florida, Port St. Lucie, Florida, USA. ehaddad@vgtifl.org
Journal:


Publication:

abstract

PURPOSE OF REVIEW:

In the present review, we will provide the scientific rationale for applying Systems biology to the development of vaccines and particularly HIV vaccines, the predictive power of systems biology on the vaccine immunological profile, the correlation between systems biology and the immunological functional profiles of different candidate vaccines, and the value of systems biology in the selection process of identifying the best-in-class candidate vaccines and in the decision process to move into in-vivo evaluation in clinical trials.

RECENT FINDINGS:

Systems biology has been recently applied to the characterization of the protective yellow fever vaccine YF17D and of seasonal flu vaccines. This has been instrumental in the identification of the components of the immune response that need to be stimulated by the vaccine in order to generate protective immunity. It is worth noting that a systems biology approach is currently being performed to identify correlates of immune protection of the RV144 Thai vaccine, the only known vaccine that showed modest protection against HIV reacquisition.

SUMMARY:

Systems biology represents a novel and powerful approach to predict the vaccine immunological profile, to identify the protective components of the immune response, and to help in the selection process of the best-in-class vaccines to move into clinical development.



Related Articles
Review Profiling immunity to HIV vaccines with systems biology.
Curr Opin HIV AIDS. 2012
Review Profiling immunity to HIV vaccines with systems biology.
Andersen-Nissen E, Heit A, McElrath MJ. Curr Opin HIV AIDS. 2012 Jan; 7(1):32-7.
Review Systems vaccinology: its promise and challenge for HIV vaccine development.
Curr Opin HIV AIDS. 2012
Review Systems vaccinology: its promise and challenge for HIV vaccine development.
Nakaya HI, Pulendran B. Curr Opin HIV AIDS. 2012 Jan; 7(1):24-31.
Review Overcoming limitations in the systems vaccinology approach: a pathway for accelerated HIV vaccine development.
Curr Opin HIV AIDS. 2012
Review Overcoming limitations in the systems vaccinology approach: a pathway for accelerated HIV vaccine development.
Zak DE, Aderem A. Curr Opin HIV AIDS. 2012 Jan; 7(1):58-63.
Systems biology in understanding HIV pathogenesis and guiding vaccine development.
Curr Opin HIV AIDS. 2012
Systems biology in understanding HIV pathogenesis and guiding vaccine development.
Sekaly R, Pulendran B. Curr Opin HIV AIDS. 2012 Jan; 7(1):1-3.
Review New approaches to design HIV-1 T-cell vaccines.
Curr Opin HIV AIDS. 2010
Review New approaches to design HIV-1 T-cell vaccines.
Perrin H, Canderan G, Sékaly RP, Trautmann L. Curr Opin HIV AIDS. 2010 Sep; 5(5):368-76.

To top Home


Show map | Diseases | Vaccination | Chronic disease | Medicine | Pregnancy | Heat & Sunburn | Cold | Security | Useful tips | Faq | News

TraveldoctorOnline 2001 • Disclaimer webmaster

The contents within traveldoctoronline are presented only for informational purposes and cannot substitute for professional health care or any other medical treatment.All users of this website with health problems should be oblige always to consult their medical doctor before starting any treatment.